SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001100412-16-000054
Filing Date
2016-11-03
Accepted
2016-11-03 08:36:26
Documents
63
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q a09301610-q.htm 10-Q 965679
2 EXHIBIT 31.1 a09302016ex311.htm EX-31.1 14784
3 EXHIBIT 31.2 a09302016ex312.htm EX-31.2 14052
4 EXHIBIT 32.1 a09302016ex321.htm EX-32.1 11774
  Complete submission text file 0001100412-16-000054.txt   5914241

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT arry-20160930.xml EX-101.INS 1193394
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT arry-20160930.xsd EX-101.SCH 46560
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT arry-20160930_cal.xml EX-101.CAL 69054
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT arry-20160930_def.xml EX-101.DEF 266741
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT arry-20160930_lab.xml EX-101.LAB 664498
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT arry-20160930_pre.xml EX-101.PRE 409853
Mailing Address 3200 WALNUT STREET BOULDER CO 80301
Business Address 3200 WALNUT STREET BOULDER CO 80301 3033816600
ARRAY BIOPHARMA INC (Filer) CIK: 0001100412 (see all company filings)

IRS No.: 841460811 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-16633 | Film No.: 161970291
SIC: 2834 Pharmaceutical Preparations